Bispecific Antibodies in the Treatment of Hematologic Malignancies.

MLA

Duell, Johannes, et al. “Bispecific Antibodies in the Treatment of Hematologic Malignancies.” Clinical Pharmacology & Therapeutics, vol. 106, no. 4, Oct. 2019, pp. 781–91. EBSCOhost, https://doi.org/10.1002/cpt.1396.

APA

Duell, J., Lammers, P. E., Djuretic, I., Chunyk, A. G., Alekar, S., Jacobs, I., & Gill, S. (2019). Bispecific Antibodies in the Treatment of Hematologic Malignancies. Clinical Pharmacology & Therapeutics, 106(4), 781–791. https://doi.org/10.1002/cpt.1396

Chicago

Duell, Johannes, Philip E. Lammers, Ivana Djuretic, Allison G. Chunyk, Shilpa Alekar, Ira Jacobs, and Saar Gill. 2019. “Bispecific Antibodies in the Treatment of Hematologic Malignancies.” Clinical Pharmacology & Therapeutics 106 (4): 781–91. doi:10.1002/cpt.1396.